Intranet
Houssem Redha Chenane | IAME
Houssem Redha Chenane Position: Contract researcher / PhD Student Affiliation: Inserm
Team: PREVIST

PhD Thesis

Étude de marqueurs sérologiques et génomiques des virus respiratoires SARS-CoV-2 et VRS

School: Université Paris Cité

Supervisor: Diane Descamps & M-A Rameix-Welti

Defense date: 2025-01-24

Publications

High sera levels of SARS-CoV-2 N antigen are associated with death in hospitalized COVID-19 patients

2023

DOI

PubMed

Copy reference

Journal of Medical Virology

Chenane HR et al.Chenane HR, Lingas G, Menidjel R, Laouenan C, Tubiana S, Descamps D, Le Hingrat Q, Abel L, Guedj J, Malhotra S, Kumar-Singh S, Visseaux B, Ghosn J, Charpentier C, Lebourgeois S, French COVID Cohort Study Group

SARS-CoV-2 viability and viral RNA persistence on microbiological agar plates

2023

DOI

PubMed

Copy reference

The Journal of Hospital Infection

Farfour E et al.Farfour E, Lebourgeois S, Chenane HR, Charpentier C, Pascreau T, Jolly E, Descamps D, Vasse M, Visseaux B

Temporal dynamics of RSV shedding and genetic diversity in adults during the COVID-19 pandemic in a French hospital, early 2021

2023

DOI

PubMed

Copy reference

Virus Research

Coppée R et al.Coppée R, Chenane HR, Bridier-Nahmias A, Tcherakian C, Catherinot E, Collin G, Lebourgeois S, Visseaux B, Descamps D, Vasse M, Farfour E

Decreasing humoral response among healthcare workers up to 4 months after two doses of BNT162b2 vaccine

2022

DOI

PubMed

Copy reference

The Journal of Infection

Ferré VM et al.Ferré VM, Lebourgeois S, Menidjel R, Collin G, Chenane HR, Guindi MO, Yazdanpanah Y, Timsit JF, Charpentier C, Descamps D, Fidouh N, Visseaux B

Alpha (B.1.1.7) and Delta (B.1.617.2 - AY.40) SARS-CoV-2 variants present strong neutralization decay at M4 post-vaccination and a faster replication rates than D614G (B.1) lineage

2022

DOI

PubMed

Copy reference

The Journal of Infection

Lebourgeois S et al.Lebourgeois S, Menidjel R, Chenane HR, Ferré VM, Collin G, Damond F, Coppée R, Yazdanpanah Y, Timsit JF, Houhou-Fidouh N, Descamps D, Charpentier C, Visseaux B

Vaccine Ab neutralization against Omicron and SARS-CoV-2 variants using neutralization and specific ELISA assays

2022

DOI

PubMed

Copy reference

The Journal of Infection

Ferré VM et al.Ferré VM, Lebourgeois S, Chenane HR, Menidjel R, Masson C, Collin G, Visseaux B, Descamps D, Fidouh N, Charpentier C

Differential activation of human neutrophils by SARS-CoV-2 variants of concern

2022

DOI

PubMed

Copy reference

Frontiers in Immunology

Lebourgeois S et al.Lebourgeois S, David A, Chenane HR, Granger V, Menidjel R, Fidouh N, Noël B, Delelis O, Richetta C, Charpentier C, Chollet-Martin S, Descamps D, Visseaux B, de Chaisemartin L

Earlier In Vitro Viral Production With SARS-CoV-2 Alpha Than With Beta, Gamma, B, or A.27 Variants

2021

DOI

PubMed

Copy reference

Frontiers in Cellular and Infection Microbiology

Lebourgeois S et al.Lebourgeois S, Chenane HR, Houhou-Fidouh N, Menidjel R, Ferré VM, Collin G, Benmalek N, Coppée R, Larrouy L, Yazdanpanah Y, Timsit JF, Charpentier C, Descamps D, Visseaux B